JP2024543013A5 - - Google Patents
Info
- Publication number
- JP2024543013A5 JP2024543013A5 JP2024525592A JP2024525592A JP2024543013A5 JP 2024543013 A5 JP2024543013 A5 JP 2024543013A5 JP 2024525592 A JP2024525592 A JP 2024525592A JP 2024525592 A JP2024525592 A JP 2024525592A JP 2024543013 A5 JP2024543013 A5 JP 2024543013A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273370P | 2021-10-29 | 2021-10-29 | |
| US63/273,370 | 2021-10-29 | ||
| PCT/US2022/078835 WO2023077040A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024543013A JP2024543013A (ja) | 2024-11-19 |
| JP2024543013A5 true JP2024543013A5 (https=) | 2025-10-31 |
| JPWO2023077040A5 JPWO2023077040A5 (https=) | 2025-10-31 |
Family
ID=84785201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525592A Pending JP2024543013A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250268903A1 (https=) |
| EP (1) | EP4423058A1 (https=) |
| JP (1) | JP2024543013A (https=) |
| KR (1) | KR20240099355A (https=) |
| CN (1) | CN118451058A (https=) |
| WO (1) | WO2023077040A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121605099A (zh) * | 2023-08-10 | 2026-03-03 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
| TW202530177A (zh) * | 2023-10-13 | 2025-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 醯胺取代的環烷基類化合物、其製備方法及其在醫藥上的應用 |
| JP7788532B2 (ja) | 2023-12-15 | 2025-12-18 | イーライ リリー アンド カンパニー | Ｒｘｆｐ１受容体アゴニスト |
| WO2026041118A1 (zh) * | 2024-08-22 | 2026-02-26 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE216580T1 (de) | 1993-07-16 | 2002-05-15 | Merck & Co Inc | Benzoxazinon- und benzopyrimidinon- piperidinyl- verbindungen als tokolytische oxytocin-rezeptor- antagonisten |
| WO2013165606A1 (en) * | 2012-05-04 | 2013-11-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| AR124193A1 (es) * | 2020-12-08 | 2023-02-22 | Astrazeneca Ab | Compuestos moduladores de rxfp1 |
-
2022
- 2022-10-28 EP EP22835522.8A patent/EP4423058A1/en active Pending
- 2022-10-28 US US18/701,276 patent/US20250268903A1/en active Pending
- 2022-10-28 CN CN202280084766.5A patent/CN118451058A/zh active Pending
- 2022-10-28 WO PCT/US2022/078835 patent/WO2023077040A1/en not_active Ceased
- 2022-10-28 JP JP2024525592A patent/JP2024543013A/ja active Pending
- 2022-10-28 KR KR1020247017528A patent/KR20240099355A/ko active Pending